Tri Locum Partners LP Evolus, Inc. Transaction History

Tri Locum Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.81 - $11.05 $1.25 Million - $1.77 Million	160,269 New	160,269 $1.36 Million
Q2 2022 Aug 15, 2022	BUY	$10.22 - $13.94 $2.23 Million - $3.04 Million	217,767 New	217,767 $2.53 Million
Q3 2021 Nov 15, 2021	SELL	$7.36 - $13.67 $3.66 Million - $6.79 Million	-496,826 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $3.5 Million - $5.8 Million	415,801 Added 513.18%	496,826 $6.29 Million
Q1 2021 May 17, 2021	BUY	$3.2 - $16.51 $259,280 - $1.34 Million	81,025 New	81,025 $1.05 Million

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.